Abstract
There is no substitution for seeing theory applied in real-life situations.
These case reports highlight a number of different dry eye disease situations including dry eye post LASIK, meibomian gland dysfunction and dry eye disease coexisting with other ocular surface disease.
Each case study has key learnings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alex A, Edwards A, Hays JD, Kerkstra M, Shih A, de Paiva CS, Pflugfelder SC (2013) Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci 54:3325–3332
Ambrósio R Jr, Tervo T, Wilson SE (2008) LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg 24:396–407
Bulbulia A, Shaik R, Khan N, Vayej S, Kistnasamy B, Page T (1995) Ocular health status of chemical industrial workers. Optom Vis Sci 72:233–240
Craig JP, Tomlinson A (1997) Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 74:8–13
Dougherty JM, McCulley JP, Silvany RE, Meyer DR (1991) The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 32:2970–2975
Duffey RJ, Leaming D (2005) US trends in refractive surgery: 2004 ISRS/AAO Survey. J Refract Surg 21:742–748
Guillon JP, Guillon M (1993) Tear film examination of the contact lens patient. Optician 206:21–29
Hamrah P, Alipour F, Jiang S, Sohn JH, Foulks GN (2011) Optimizing evaluation of lissamine green parameters for ocular surface staining. Eye (Lond) 25:1429–1434
Henriquez AS, Korb DR (1981) Meibomian glands and contact lens wear. Br J Ophthalmol 65:108–111
Huo AP, Lin KC, Chou CT (2010) Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren’s syndrome. Int J Rheum Dis 13:39–47
James MJ, Gibson RA, Cleland LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71:343S–348S
Knop E, Knop N, Millar T, Obata H, Sullivan DA (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland. Invest Ophthalmol Vis Sci 52:1938–1978
Korb DR, Blackie CA (2013a) Debridement-scaling: a new procedure that increases Meibomian gland function and reduces dry eye symptoms. Cornea 32:1554–1557
Korb DR, Blackie CA (2013b) Using goggles to increase periocular humidity and reduce dry eye symptoms. Eye Contact Lens 39:273–276
Mark KA, Sparacio RM, Voigt A, Marenus K, Sarnoff DS (2003) Objective and quantitative improvement of rosacea-associated erythema after intense pulsed light treatment. Dermatol Surg 29:600–604
Nichols KK, Nichols JJ, Mitchell GL (2004) The reliability and validity of McMonnies Dry Eye Index. Cornea 23:365–371
Olenik A, Jimenez-Alfaro I, Alejandre-Alba N, Mahillo-Fernandez I (2013) A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging 8:1133–1138
Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118:615–621
Sobolewska B, Doycheva D, Deuter C, Pfeffer I, Schaller M, Zierhut M (2014) Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea 33:257–260
Toyos R, Buffa CM, Youngerman SM (2005) Dry eye and Sjogren’s syndrome Case Reports. ASCRS EyeWorld
Wilson SE (2001) Laser in situ keratomileusis–induced (presumed) neurotrophic epitheliopathy. Ophthalmology 108:1082–1087
Wilson SE, Ambrósio R (2001) Laser in situ keratomileusis – induced neurotrophic epitheliopathy. Am J Ophthalmol 132:405–406
Compliance with Ethical Requirements
Jennifer Craig, Colin Chan, Fernando Faria Correia, Issac Ramos, Marcella Salomao and Renato Ambrosio Jr. declare that they have no conflict of interest. Victor Caparas has received speaker’s honoraria from Alcon and Allergan. He does not own any stock in either company. Kazuo Tsubota is a consultant for Santen Pharmaceutical Co., Ltd. Kazuo Tsubota has received research grants from Santen Pharmaceutical Co., Ltd.; Kowa Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; and JIN Co., Ltd. Kazuo Tsubota and Minako Kaido hold patent rights for the method and the apparatus used for the measurement of functional visual acuity (US patent no: 7470026).
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
No animal studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Craig, J.P. et al. (2015). Case Studies. In: Chan, C. (eds) Dry Eye. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44106-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-44106-0_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44105-3
Online ISBN: 978-3-662-44106-0
eBook Packages: MedicineMedicine (R0)